Johnson and Johnson Forks Over More than $1 Billion Dollars

Pharmaceutical giant Johnson & Johnson has announced that it will fork over more than $1 billion to several states, including Louisiana, and to the federal government to settle investigations that it improperly marketed its antipsychotic drug Risperdal. The states and federal government were looking into this because even an otherwise safe medication can become a dangerous